Stock Events

Vertex Pharmaceuticals (VX1.XETRA) Q3 2024 Earnings

VX1.XETRA -1.50%
1AugConfirmed
Q4 2023
Q1 2024
Q2 2024
Q3 2024
-11.89
-6.45
-1.02
4.42

Details

Expected EPS
-10.774047968749999
Actual EPS
-11.8902025
Surprise EPS
-1.12
Surprise Percent
+10.36%

Description

Vertex Pharmaceuticals (VX1.XETRA) has reported earnings of -11.8902025 per share for Q3 2024.

0 Comments

Share your thoughts